GSK's Russian subsidiary to market CSL Behring's products in ex-Soviet republics
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline's Russian subsidiary has entered in to an agreement with CSL Behring to market and distribute its blood plasma protein biotherapeutics in ex-Soviet republics.